Pfizer Global medical Grants (GMG) supports the global healthcare community's independant intitiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer's medical and/or scientific strategies.
Pfizer's GMG competitive grant program involves a publicaly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.
For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent inititiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.
The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional educaiton and/or healthcare improvement.
If the project involves multiple departments within an institution and/or between different institutions/organization/associations. All institutions must have a relevant role and the requesting organization must have a key role in the project.
For projects offereing continuing education credit, the requesting organization must be accredited.
January 25, 2022: Application due
April 2022: Anticipated grant award notification date